Valbiotis (XPAR:ALVAL) Other Current Receivables : €1.72 Mil (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Valbiotis Other Current Receivables?

Valbiotis's Other Current Receivables for the quarter that ended in Dec. 2023 was €1.72 Mil.

Valbiotis's quarterly Other Current Receivables declined from Dec. 2022 (€2.54 Mil) to Jun. 2023 (€0.01 Mil) but then increased from Jun. 2023 (€0.01 Mil) to Dec. 2023 (€1.72 Mil).

Valbiotis's annual Other Current Receivables declined from Dec. 2021 (€2.72 Mil) to Dec. 2022 (€2.54 Mil) and declined from Dec. 2022 (€2.54 Mil) to Dec. 2023 (€1.72 Mil).

Valbiotis Other Current Receivables Historical Data

The historical data trend for Valbiotis's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valbiotis Other Current Receivables Chart

Valbiotis Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Receivables

Get a 7-Day Free Trial

2.19

2.15

2.72

2.54

1.72

Valbiotis Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Current Receivables	Get a 7-Day Free Trial											2.72	2.14	2.54	0.01	1.72

Valbiotis Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

Valbiotis Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Valbiotis's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Valbiotis (XPAR:ALVAL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valbiotis SA (XPAR:ALVAL) » Definitions » Other Current Receivables

Comparable Companies

Traded in Other Exchanges

8JD:Germany

Address

12F rue Paul VATINE, Perigny, La Rochelle, FRA, 17180

Website

http://www.valbiotis.com

Valbiotis SA is a research & development company. It is engaged in scientific innovation for preventing and combating metabolic diseases. Valbiotis has adopted an approach, aiming to revolutionize healthcare by developing a new class of Nutrition Health products designed to reduce the risk of major metabolic diseases, based on a multi-target approach by the use of plant-based ingredients.

Valbiotis (XPAR:ALVAL) Headlines

No Headlines